Equate Maximum Strength Ranitidine recalls
The FDA has published 2 recalls involving Equate Maximum Strength Ranitidine since 2019. The latest was reported on 20 Nov 2019. Most were for nitrosamine impurity. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 20 Nov 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why equate maximum strength ranitidine is recalled
Companies
By year
All equate maximum strength ranitidine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Equate Maximum Strength Ranitidine Tablets recalled by Apotex | Apotex | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer recalled | Apotex | Nitrosamine Impurity | Nationwide |
Should you stop taking Equate Maximum Strength Ranitidine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.